跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NINTEDANIB SANDOZ 150 MG CAPSULAS BLANDAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
NINTEDANIB SANDOZ 150 MG CAPSULAS BLANDAS EFG
Approved
STANDARD
NINTEDANIB SANDOZ 150 MG CAPSULAS BLANDAS EFG
Sandoz Farmaceutica S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 16, 2025
Approval ID
fcfd034d183b94b4
Company
Sandoz Farmaceutica S.A.
Type
Standard
Approval Details
Approval Id
fcfd034d183b94b4
Drug Cima Aemps Name
NINTEDANIB SANDOZ 150 MG CAPSULAS BLANDAS EFG
Register Number
90074
Holder Company Name
Sandoz Farmaceutica S.A.
Marketing Company Name
Sandoz Farmaceutica S.A.
Authorization Date
2025-01-16
Dosage Form
CÁPSULA BLANDA
Dose
150 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Sandoz Farmaceutica S.A.
Active Ingredients
NINTEDANIB ESILATO
180,60 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 16, 2025
Approval ID
fcfd034d183b94b4
Type
Standard
Back to CIMA-AEMPS Approvals
